In summary, we demonstrated evidence that EBI3 associated with IL-12p35, gp130, and p-STAT3 are highly expressed in CRC cells to inhibit antitumor CTL response and promote tumor growth in CRC. The gene discussed is STAT3; the disease is neoplasm.